Literature DB >> 2284902

Management of urinary incontinence in gynecological practice in Norway.

B C Eriksen1, H Sandvik, S Hunskaar.   

Abstract

In order to investigate how Norwegian gynecologists manage female urinary incontinence in their daily practice, a questionnaire about six typical case histories was sent to the members of the Norwegian Gynaecological Association. The questionnaire comprised questions about investigations, use of laboratory tests and treatment options. Of 268 questionnaires sent out, 190 were returned (71%). Frequency-volume charts were recommended by 42% of the doctors and pad-weighting tests by 12%. Urodynamic examination was recommended for 55% of the cases, but mainly in mixed incontinence (76 and 77%). Pelvic floor exercises were suggested more often to younger patients than to the elderly. Drugs were infrequently suggested, mainly following appropriate indications. Drugs and pads were recommended especially for the elderly. The recommendation rate for surgical repair was higher for young age and greater degree of stress incontinence. The modest therapeutic ambition on behalf of the elderly women lacks basis in clinical research. A general management program for female urinary incontinence would possibly standardize and improve the quality of incontinence care by gynecologists in Norway.

Entities:  

Mesh:

Year:  1990        PMID: 2284902     DOI: 10.3109/00016349009013329

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Urinary incontinence in Canada. National survey of family physicians' knowledge, attitudes, and practices.

Authors:  J Graham Swanson; Jennifer Skelly; Brian Hutchison; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2002-01       Impact factor: 3.275

2.  Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey.

Authors:  H Sandvik; S Hunskaar; A Seim; R Hermstad; A Vanvik; H Bratt
Journal:  J Epidemiol Community Health       Date:  1993-12       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.